Drugs

Research Tools and Resources

Back to Science & Research (Drugs)

Developing and sharing knowledge with researchers from the public and private sectors is at the heart of what Center for Drug Evaluation and Research (CDER) scientists do. The tools and resources that are currently available are listed below. Please check back for updates.

Learn more about scientific careers and fellowship opportunities at FDA.

Databases

Drug Development Tool Qualification Programs

CDER's Drug Development Tool (DDT) Qualification Programs allow CDER to work with submitters to guide them as they develop DDTs for specific contexts of use. CDER has programs directed toward the following DDTs:

FDA guidance documents represent FDA's current thinking on a particular subject.

Information About:

Recent Reports on Regulatory Science

Research Capabilities

Scientific Publications by FDA Staff

CDER scientists frequently share their research findings in scientific journals. Search the database of scientific publications by FDA staff.

Table of Pharmacogenomic Biomarkers in Drug Labeling

The Table of Pharmacogenomic Biomarkers in Drug Labeling is a list of FDA-approved drugs whose labels include pharmacogenomic information. Pharmacogenomics can help identify who will respond to medications, avoid adverse events, and optimize drug doses. Some of the products' labels include specific actions to be taken based on biomarker information.

Pills on person’s palm. Find out how CDER’s research ensures that new and existing drugs are safe and effective

Page Last Updated: 11/06/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English